Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

About the Cover

Cover Figure


On The Cover

Computer modeling of peptidomimetic ISS 610 and native Stat3 phosphopeptide bound to the SH2 pocket of Stat3. This illustration compares the predicted lowest energy GOLD docked conformation of the Stat3 inhibitor peptidomimetic, ISS 610 (green), to the COOH-terminal phosphotyrosine peptide (AAPY*LK, orange) of the associated Stat3 monomer in the SH2 domain of Stat3 (pale blue) determined from the crystal structure. By having access to hydrophobic and hydrogen bonding interactions on the protein surface, which are otherwise not accessible to the native phosphopeptide seequence, ISS 610 disrupts Stat3 dimerization. Thus, ISS 610 inhibits Stat3 signaling and biological functions, and induces apoptosis of oncogenically transformed cells. For details, see Turkson et al. in this issue.



[Table of Contents]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.